Hydralazine and methyldopa in thiazide-treated hypertensive patients
- 30 June 1970
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 79 (6), 798-804
- https://doi.org/10.1016/0002-8703(70)90366-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm HgJAMA, 1967
- CLINICAL AND EXPERIMENTAL STUDIES ON THE HYDRALAZINE SYNDROME AND ITS RELATIONSHIP TO SYSTEMIC LUPUS ERYTHEMATOSUSMedicine, 1967
- AUTOIMMUNE HÆMOLYTIC ANÆMIA ASSOCIATED WITH α-METHYLDOPA THERAPYThe Lancet, 1966
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966
- Effects of treatment in hypertension results of a controlled studyJournal of Chronic Diseases, 1966
- The Relative Efficacy of Guanethidine, Methyldopa and Pargyline as Antihypertensive AgentsNew England Journal of Medicine, 1965
- Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopaThe American Journal of Cardiology, 1962
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- MANAGEMENT OF SYSTEMIC ARTERIAL HYPERTENSIONArchives of Internal Medicine, 1955
- Studies on the Control of Hypertension by HyphexCirculation, 1953